Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly point » significantly poorer (Expand Search), significantly lower (Expand Search), significantly worse (Expand Search)
significantly onto » significantly longer (Expand Search), significantly lower (Expand Search), significantly worse (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significantly point » significantly poorer (Expand Search), significantly lower (Expand Search), significantly worse (Expand Search)
significantly onto » significantly longer (Expand Search), significantly lower (Expand Search), significantly worse (Expand Search)
-
2461
-
2462
-
2463
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2464
-
2465
-
2466
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2467
-
2468
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2469
-
2470
-
2471
-
2472
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2473
-
2474
-
2475
-
2476
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2477
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2478
-
2479
-
2480
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: